Placebo-Controlled Biopharma (1,910 companies)
271 CompaniesAccess all companies
Spotfolio tracks over one million companies in technology industries.
There are 271 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Placebo, Clinical, Drug, Patients, Treatment, Efficacy, Clinical-Trials, Trial, Placebo-Controlled .
Early-stage companies (61)
Established companies (181)
The majority of these companies is located in the following countries.
United States (161)
United Kingdom (12)
Example CompaniesFind companies in your area
Sermonix Pharmaceuticals Sermonix Pharmaceuticals Inc.
one-compartment all-EVA vaginal ring. -- A randomized, double-blind, active- and placebo-controlled, parallel group, multicenter study assessing the safety and protective ...
norethindrone acetate plus ethinyl estradiol. -- Phase II double-blind placebo-controlled trial of the safety, toleration and efficacy of the SERM CP-336,156 ...
Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study. -- Phase II, Double-Blind, Placebo-Controlled Trial of the Safety, Toleration ...
Randomized, DoubleBlind, Placebo-Controlled, Parallel Group, Multicenter Study -- A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, DoseRanging ...
with Polycystic Ovary Syndrome (PCOS) --A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Effect of 500 and 1000mg of INS-1 ...
with Polycystic Ovary Syndrome (PCOS). --A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Effect of several doses of an investigational
peripheral neuropathy or post-herpetic neuralgia randomised to this placebo-controlled, crossover study. Patients were recruited from four sites across Australia ...
migraine. There were 21 patients with acute migraine randomised to this placebo-controlled, crossover study. Patients were recruited from three sites across
administered to healthy male volunteers in a randomized, double blind, placebo controlled at each dose level Phase I study. - SDD-1002-023: Dose escalation ...
SDD-1004-059: A Phase II, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of XG-104 Ophthalmic ...
administered to healthy male volunteers in a randomized, double-blind, placebo-controlled, dose escalating Phase I study. - AM-111: Intratympanic treatment
FibroGen FibroGen, Inc.
ZEPHYRUS Study – FG-3019-091 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic ...
ZEPHYRUS II Study – FG-3019-095 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic ...
LAPIS@fibrogen.com COVID-19 FG-3019-098 A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Efficacy and Safety of Intravenous Pamrevlumab
Pulmonary Fibrosis (PRAISE): A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial Pamrevlumab In Idiopathic Pulmonary Fibrosis Effects of CTGF
(MS) Clinical Trials Artielle has recently completed double-blind, placebo-controlled, Phase I, dose escalation study of the safety of a single intravenous
TopicsSearch by any topic
Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.
Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.
The following topics addressed by the majority of companies help you discover major players in the field.
All companies in this field address the following more general topics.
Use CasesRegister now
Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.
Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.